MARK MANNING: Open Payments
NPI 1437150208 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 22 payments from 11 companies in 2025. Trend: 2023 $273 · 2024 $117 · 2025 $664
Food & beverage: $530Education: $134
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $111 |
| AERIN MEDICAL INC. | 1 | $101 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| GENZYME CORPORATION | 2 | $88 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| Regeneron Healthcare Solutions, Inc. | 3 | $54 |
| Amgen Inc. | 2 | $52 |
| Inspire Medical Systems, Inc. | 2 | $35 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Integra LifeSciences Corporation | 1 | $15 |
Products named: DUPIXENT, VIVAER STYLUS, NUCALA, INSPIRE, JOURNAVX, TEZSPIRE, XHANCE, ACCLARENT AERA.
Industry payments across KS — which companies pay providers there.
